INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,401 | -18.0% | 3,112 | +5.7% | 0.00% | -33.3% |
| Q2 2023 | $120,016 | +29.3% | 2,943 | +18.2% | 0.01% | +20.0% |
| Q1 2023 | $92,802 | +4.8% | 2,490 | -0.8% | 0.01% | +25.0% |
| Q4 2022 | $88,564 | +19.7% | 2,510 | +90.0% | 0.00% | +33.3% |
| Q3 2022 | $74,000 | -22.1% | 1,321 | -27.8% | 0.00% | 0.0% |
| Q2 2022 | $95,000 | +23.4% | 1,829 | +72.4% | 0.00% | +50.0% |
| Q1 2022 | $77,000 | -39.4% | 1,061 | +1.5% | 0.00% | -50.0% |
| Q4 2021 | $127,000 | +217.5% | 1,045 | +253.0% | 0.00% | +100.0% |
| Q3 2021 | $40,000 | -14.9% | 296 | +2.8% | 0.00% | 0.0% |
| Q2 2021 | $47,000 | – | 288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |